With a focus on optimizing production potential, ARTMS will continue the development of cyclotron-produced 68 Ga and other vitally important medical isotopes, while also pursuing multiple regulatory approvals. ARTMS has a variety of solid targets commercially available used in combination with ARTMS’ QUANTM Irradiation System (QIS™).
About ARTMS
Ad Statistics
Times Displayed: 365767
Times Visited: 7086 Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576
Based in Vancouver, British Columbia, Canada, ARTMS Inc. is a global leader in the development of novel technologies and products which enable the high-quality and high-yield production of the world’s most-used diagnostic imaging isotopes. ARTMS’ flagship product, the QUANTM Irradiation System TM (QIS TM ), enables decentralized, cost-effective, large-scale production of important medical isotopes such as gallium-68 ( 68 Ga), zirconium-89 ( 89 Zr), technetium‐99m ( 99m Tc) and copper-64 ( 64 Cu) using pharmaceutical distributor and hospital-based medical cyclotrons, empowering users to control their supply chain. ARTMS commercializes these award-winning and proprietary Canadian inventions on a global basis and has the prospect of revolutionizing the nuclear medicine industry.
SOURCE: ARTMS Inc.
Back to HCB News
